Anika Therapeutics announces participation in investment conferences, showcasing management and discussing orthopedic advancements.
Quiver AI Summary
Anika Therapeutics, Inc. has announced that its senior management will participate in several upcoming conferences. Dr. Cheryl Blanchard, the President and CEO, and Steve Griffin, the Chief Financial Officer, will present at the 36th Annual Piper Sandler Healthcare Conference on December 3rd, followed by Griffin's presentation at the Sidoti Small-Cap Virtual Conference on December 5th. Both executives will also take part in one-on-one investor meetings at these events. Additionally, they will engage in one-on-one meetings at the Benchmark Company's Discovery Conference on December 11th. Anika, headquartered near Boston, focuses on early intervention in orthopedics, particularly in pain management and regenerative solutions, and is committed to advancing minimally invasive products for better patient outcomes.
Potential Positives
- Participation of senior management in multiple high-profile healthcare conferences enhances the company's visibility and connects them with potential investors.
- Dr. Cheryl Blanchard, President and CEO, represents strong leadership presence at these events, showcasing commitment to investor engagement.
- Focus on high opportunity spaces within orthopedics, such as Osteoarthritis Pain Management and Regenerative Solutions, positions Anika as a key player in a growing market.
Potential Negatives
- None
FAQ
What conferences will Anika Therapeutics participate in?
Anika Therapeutics will participate in the Piper Sandler Healthcare Conference, Sidoti Small-Cap Virtual Conference, and Benchmark Company Discovery Conference.
Who will present at the Piper Sandler Healthcare Conference?
Dr. Cheryl Blanchard and Steve Griffin will present at the Piper Sandler Healthcare Conference on December 3rd.
What is Anika Therapeutics known for?
Anika Therapeutics is known for its advancements in joint preservation and early intervention orthopedic care.
How can investors schedule meetings with Anika's management?
Investors can schedule meetings by contacting Anika’s Investor Relations at [email protected].
Where is Anika Therapeutics headquartered?
Anika Therapeutics is headquartered outside of Boston, Massachusetts.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ANIK Hedge Fund Activity
We have seen 47 institutional investors add shares of $ANIK stock to their portfolio, and 67 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 157,707 shares (+9.8%) to their portfolio in Q3 2024
- RIVERWATER PARTNERS LLC added 86,037 shares (+539.1%) to their portfolio in Q3 2024
- AQR CAPITAL MANAGEMENT LLC removed 76,681 shares (-71.4%) from their portfolio in Q3 2024
- NUVEEN ASSET MANAGEMENT, LLC removed 58,761 shares (-58.7%) from their portfolio in Q3 2024
- MORGAN STANLEY removed 49,011 shares (-9.8%) from their portfolio in Q3 2024
- CITADEL ADVISORS LLC removed 47,063 shares (-52.8%) from their portfolio in Q3 2024
- VIRTUS INVESTMENT ADVISERS, INC. removed 45,579 shares (-100.0%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that senior management will participate in the following upcoming conferences.
36th Annual Piper Sandler Healthcare Conference in New York, NY on December 3 rd . Dr. Cheryl Blanchard, President and CEO of Anika and Steve Griffin, Executive Vice President and Chief Financial Officer, are scheduled to present at 10:30am ET. Management will also participate in one-on-one investor meetings throughout the event.
Sidoti Small-Cap Virtual Conference on December 5 th . Steve Griffin, Executive Vice President and Chief Financial Officer, is scheduled to present at 10:45am ET. Mr. Griffin will also participate in one-on-one investor meetings throughout the event.
The Benchmark Company 13th Annual Discovery One-on-One Investor Conference in New York, NY on December 11 th . Dr. Cheryl Blanchard, President and CEO of Anika and Steve Griffin, Executive Vice President and Chief Financial Officer will participate in one-on-one investor meetings throughout the event.
For more information about these events or to schedule a one-on-one meeting with Anika’s senior management, please contact Anika’s Investor Relations at [email protected] .
About Anika
Anika Therapeutics, Inc.
(NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management and Regenerative Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anika’s global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit
www.anika.com
.
ANIKA, ANIKA THERAPEUTICS, CINGAL, HYALOFAST, INTEGRITY, MONOVISC, ORTHOVISC, TACTOSET, and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use.
For Investor Inquiries:
Anika Therapeutics, Inc.
Matt Hall, 781-457-9554
Director, Corporate Development and Investor Relations
[email protected]
